Changes in gene expression profile in two multidrug resistant cell lines derived from a same drug sensitive cell line.

[1]  P. Krammer,et al.  Tumor Immunology , 2018, Medical Immunology.

[2]  R. Maia,et al.  Multidrug resistance in chronic myeloid leukaemia: how much can we learn from MDR–CML cell lines? , 2013, Bioscience reports.

[3]  R. R. Lopes,et al.  Characterization of a multidrug-resistant chronic myeloid leukemia cell line presenting multiple resistance mechanisms , 2013, Molecular and Cellular Biochemistry.

[4]  K. Capaccione,et al.  The Notch signaling pathway as a mediator of tumor survival. , 2013, Carcinogenesis.

[5]  S. Armstrong,et al.  Notch pathway activation targets AML-initiating cell homeostasis and differentiation , 2013, The Journal of experimental medicine.

[6]  J. McMurray,et al.  Notch activation inhibits AML growth and survival: a potential therapeutic approach , 2013, The Journal of experimental medicine.

[7]  J. den Hertog,et al.  Knocking Down Low Molecular Weight Protein Tyrosine Phosphatase (LMW-PTP) Reverts Chemoresistance through Inactivation of Src and Bcr-Abl Proteins , 2012, PloS one.

[8]  S. Correa,et al.  Wnt/β-catenin pathway regulates ABCB1 transcription in chronic myeloid leukemia , 2012, BMC Cancer.

[9]  A. Mencalha,et al.  A comparative proteomic study identified LRPPRC and MCM7 as putative actors in imatinib mesylate cross-resistance in Lucena cell line , 2012, Proteome Science.

[10]  W. T. Beck,et al.  Notch1 regulates the expression of the multidrug resistance gene ABCC1/MRP1 in cultured cancer cells , 2011, Proceedings of the National Academy of Sciences.

[11]  M. Peppelenbosch,et al.  Hedgehog signaling maintains chemoresistance in myeloid leukemic cells , 2010, Oncogene.

[12]  J. Sandrini,et al.  Relationships between multidrug resistance (MDR) and stem cell markers in human chronic myeloid leukemia cell lines. , 2010, Leukemia research.

[13]  J. Sprowl,et al.  The temporal relationship between ABCB1 promoter hypomethylation, ABCB1 expression and acquisition of drug resistance , 2010, The Pharmacogenomics Journal.

[14]  E. Hovig,et al.  Upregulation of stem cell genes in multidrug resistant K562 leukemia cells. , 2009, Leukemia research.

[15]  P. Barbry,et al.  Gene expression profiling of imatinib and PD166326-resistant CML cell lines identifies Fyn as a gene associated with resistance to BCR-ABL inhibitors , 2009, Molecular Cancer Therapeutics.

[16]  Sathish Kumar Mungamuri,et al.  Survival signaling by Notch1: mammalian target of rapamycin (mTOR)-dependent inhibition of p53. , 2006, Cancer research.

[17]  I. Pogribny,et al.  Role of DNA hypomethylation in the development of the resistance to doxorubicin in human MCF-7 breast adenocarcinoma cells. , 2006, Cancer letters.

[18]  Ruoping Tang,et al.  MRP3, BCRP, and P-Glycoprotein Activities are Prognostic Factors in Adult Acute Myeloid Leukemia , 2005, Clinical Cancer Research.

[19]  J. Esteve,et al.  Adverse prognostic impact of CD36 and CD2 expression in adult de novo acute myeloid leukemia patients. , 2005, Leukemia research.

[20]  Andrew P. Weng,et al.  Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia , 2004, Science.

[21]  D. Mahadevan,et al.  Targeting the multidrug resistance-1 transporter in AML: molecular regulation and therapeutic strategies. , 2004, Blood.

[22]  Jean YH Yang,et al.  Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.

[23]  R. Gentleman,et al.  A Model-Based Background Adjustment for Oligonucleotide Expression Arrays , 2004 .

[24]  Yulia Nefedova,et al.  Involvement of Notch-1 signaling in bone marrow stroma-mediated de novo drug resistance of myeloma and other malignant lymphoid cell lines. , 2004, Blood.

[25]  Benjamin M. Bolstad,et al.  affy - analysis of Affymetrix GeneChip data at the probe level , 2004, Bioinform..

[26]  J. Melo,et al.  MDR1 gene overexpression confers resistance to imatinib mesylate in leukemia cell line models. , 2003, Blood.

[27]  C. Gattass,et al.  Pentacyclic triterpenes from Chrysobalanaceae species: cytotoxicity on multidrug resistant and sensitive leukemia cell lines. , 2003, Cancer letters.

[28]  A. Tsimberidou,et al.  Evaluation of the clinical relevance of the expression and function of P-glycoprotein, multidrug resistance protein and lung resistance protein in patients with primary acute myelogenous leukemia. , 2002, Leukemia research.

[29]  Timothy McCaffrey,et al.  A link between diabetes and atherosclerosis: Glucose regulates expression of CD36 at the level of translation , 2001, Nature Medicine.

[30]  M. Capella,et al.  Multidrug resistance in tumour cells: characterization of the multidrug resistant cell line K562-Lucena 1. , 2001, Anais da Academia Brasileira de Ciencias.

[31]  J. Zalcberg,et al.  Altered methylation of the human MDR1 promoter is associated with acquired multidrug resistance. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[32]  A. Duncan,et al.  Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. , 1992, Science.

[33]  R. Ozols,et al.  The role of glutathione in drug resistance. , 1990, Cancer treatment reviews.

[34]  I. Pastan,et al.  Isolation and sequence of the promoter region of the human multidrug-resistance (P-glycoprotein) gene. , 1987, The Journal of biological chemistry.

[35]  T. Tsuruo,et al.  Potentiation of vincristine and Adriamycin effects in human hemopoietic tumor cell lines by calcium antagonists and calmodulin inhibitors. , 1983, Cancer research.

[36]  R L Juliano,et al.  A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. , 1976, Biochimica et biophysica acta.

[37]  C. Lozzio,et al.  Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. , 1975, Blood.

[38]  Pooja Mittal,et al.  A novel signaling pathway impact analysis , 2009, Bioinform..

[39]  Gordon K. Smyth,et al.  limma: Linear Models for Microarray Data , 2005 .

[40]  M. Gottesman.  Mechanisms of cancer drug resistance. , 2002, Annual review of medicine.

[41]  P. Borst,et al.  Mammalian ABC transporters in health and disease. , 2002, Annual review of biochemistry.

[42]  B. Dörken,et al.  Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia. , 2000, Haematologica.

[43]  T. Litman,et al.  Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes. , 1999, Cancer research.

[44]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .